Noriko Satake

Title: Noriko Satake: Innovator in Cancer Research

Introduction

Noriko Satake is a prominent inventor based in Davis, CA (US). She has made significant contributions to the field of cancer research, particularly in the identification and isolation of cancer stem cells. With a total of 2 patents, her work has the potential to impact cancer treatment and understanding.

Latest Patents

Noriko Satake's latest patents include innovative methods for selecting and isolating cancer stem cells. These methods utilize a fluorescent glucose analog to identify cancer stem cells from biological samples or cell cultures. The invention is based on the discovery that cancer stem cells exhibit a lower level of fluorescence compared to non-cancer stem cells. Additionally, her work includes methods for selecting leukemia stem cells and their subpopulations. Another notable patent involves antisense compounds and modified oligonucleotides conjugated to anti-CD22 antibodies, which are useful for hybridizing to complementary nucleic acids within cells.

Career Highlights

Throughout her career, Noriko has worked with esteemed organizations such as the University of California and Ionis Pharmaceuticals, Inc. Her research has been pivotal in advancing the understanding of cancer biology and developing targeted therapies.

Collaborations

Noriko has collaborated with notable colleagues, including Nitin Nitin and Michael Oestergaard, contributing to a rich exchange of ideas and innovations in her field.

Conclusion

Noriko Satake's contributions to cancer research through her patents and collaborations highlight her role as a leading inventor in the scientific community. Her work continues to pave the way for advancements in cancer treatment and understanding.